Oric Pharmaceuticals Inc (ORIC)
EBITDA Growth
-24.93%
Quarterly · Period ending:
ORIC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-24.93%period ending
Latest reported-24.93%period ending
ORIC Quarterly EBITDA YoY % (-41.25% → -24.93%)
Year-over-year change
High-resolution chart · PNG
ORIC ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -24.9327% | |
| -19.4421% | |
| 16.1598% | |
| 5.8228% | |
| -13.7389% | |
| -20.0768% | |
| -28.2752% | |
| -35.9819% | |
| -39.7002% | |
| -4.4656% | |
| -36.2476% | |
| -23.1915% | |
| -13.1986% | |
| -3.4224% | |
| 8.615% | |
| -12.4334% | |
| 3.5936% | |
| -40.3333% | |
| -39.3546% | |
| -46.9534% | |
| -91.1097% | |
| -89.3296% | |
| -90.2835% | |
| -81.4999% | |
| -78.0488% | |
| -41.2516% |